Viewing Study NCT00001060


Ignite Creation Date: 2025-12-25 @ 2:03 AM
Ignite Modification Date: 2025-12-26 @ 12:28 AM
Study NCT ID: NCT00001060
Status: COMPLETED
Last Update Posted: 2013-05-06
First Post: 1999-11-02
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Phase I Trial of HIV-1 C4-V3 Polyvalent Peptide Vaccine in HIV-1 Infected Persons
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module References Module